Hipertensión pulmonar Parte I de III

Pulmonary Hypertension Part I from III

Contenido principal del artículo

Frank Boris Pernett Alvarado

Resumen

La Hipertensión Pulmonar Arterial (HPA) hasta hace muy poco tiempo era considerada una manifestación final de algunas enfermedades y en el caso de la HPA Idiopática, una enfermedad terminal con muy pocas opciones de manejo. En los últimos años ha aumentado mucho el conocimiento de la fisiopatología y se han desarrollado nuevos tratamientos que han dado una luz de esperanza a los pacientes que sufren esta enfermedad. A pesar de esto, el diagnóstico es, generalmente, un reto clínico y los costos de los nuevos tratamientos hacen difícil su utilización en países de bajos ingresos per cápita.

Palabras clave:

Descargas

Los datos de descargas todavía no están disponibles.

Detalles del artículo

Referencias (VER)

Rubin, L.J., Executive Summary: Diagnosis and Management of Pulmonary Arterial Hypertension: ACCP Evidence-Based Clinical Practice Guidelines. Chest, 2004; 126(1_suppl): p.4S-6.

Simonneau, G., et al., Clinical classification of pulmonary hypertension. J Am Coll Cardiol, 2004;43(12 Suppl S): p. 5S-12S.

Hampl, V. and J. Herget, Role of Nitric Oxide in the Pathogenesis of Chronic Pulmonary Hypertension. Physiol. Rev., 2000;80(4):1337-1372.

Stamler, J.S., et al. Nitric oxide regulates basal systemic and pulmonary vascular resistance in healthy humans. Circulation, 1994; 89(5):2035-40.

Xue, C., et al. Distribution of ONS in normoxic vs. hypoxic rat lung: upregulation of ONS by chronic hypoxia. Am J Physiol, 1994; 267(6): L667-78.

Menzel, L., et al. Temporal nitric oxide dynamics in the paranasal sinuses during humming. J Appl Physiol, 2005; 98(6): 2064-71.

Demoncheaux, E.A.G., et al. Decreased Whole Body Endogenous Nitric Oxide Production in Patients with Primary Pulmonary Hypertension. Journal of Vascular Research, 2005; 42(2):133-136.

Kinsella, J.P., et al. Superoxide Dismutase Improves Gas Exchange and Pulmonary Hemodynamics in Premature Lambs 10. 1164/rccm.200501-146OC. Am. J. Respir. Crit. Care Med., 2005;172(6): 745-749.

Hoeper, M.M. and L.J. Rubin, Update in Pulmonary Hypertension 2005 10.1164/rccm.2512003. Am. J. Respir. Crit. Care Med., 2006;173(5): 499-505.

Achcar, R.O.D., et al. Loss of Caveolin and Heme Oxygenase Expression in Severe Pulmonary Hypertension 10.1378/ chest.129.3.696. Chest, 2006;129(3):696-705.

Rudarakanchana, N., R.C. Trembath, and N.W. Morrell, New insights into the pathogenesis and treatment of primary pulmonary hypertension. Thorax, 2001;56(11):888-890.

Elliott, C.G. Genetics of pulmonary arterial hypertension: current and future implications. Semin Respir Crit Care Med, 2005. 26(4): 365-71.

Benisty, J.I., et al. Elevated Basic Fibroblast Growth Factor Levels in Patients With Pulmonary Arterial Hypertension. Chest, 2004; 126(4): 1255-1261.

Tamby, M.C., et al. Anti-endothelial cell antibodies in idiopathic and systemic sclerosis associated pulmonary arterial hypertension. Thorax, 2005; 60(9): 765-772.

Kanmogne, G.D. Noninfectious pulmonary complications of HIV/ AIDS. Curr Opin Pulm Med, 2005;11(3): 208-12.

Zuber, J.P., et al. Pulmonary arterial hypertension related to HIV infection: improved hemodynamics and survival associated with antiretroviral therapy. Clin Infect Dis, 2004; 38(8):1178-85.

Cool, C.D., et al. Expression of human herpesvirus 8 in primary pulmonary hypertension. N Engl J Med, 2003;349(12):1113-22.

Montani, D., et al. Human herpes virus 8 in HIV and non-HIV infected patients with pulmonary arterial hypertension in France. Aids, 2005;19(11):1239-40.

Castro, O. and M.T. Gladwin, Pulmonary hypertension in sickle cell disease: mechanisms, diagnosis, and management. Hematol Oncol Clin North Am, 2005;19(5): 881-96, vii.

Rhodes, J. Comparative physiology of hypoxic pulmonary hypertension: historical clues from brisket disease. J Appl Physiol, 2005; 98(3):1092-1100.

Stenmark, K.R., et al. Hypoxia, leukocytes, and the pulmonary circulation. J Appl Physiol, 2005;98(2):715-721.

Moudgil, R., E.D. Michelakis, and S.L. Archer, Hypoxic pulmonary vasoconstriction. J Appl Physiol, 2005;98(1):390-403.

Citado por